YEM Search

搜索结果

SPTAN1

靶点ID:TCMBANKGE007665

靶点别名:EIEE5; NEAS; SPTA2

靶点描述:spectrin alpha, non-erythrocytic 1

染色体:9

染色体位置:9q34.11

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:11273

OMIM_Link:182810

Ensembl_Link:ENSG00000197694

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN014187	seo-wenyujinacid B		C2H6OS or HSCH2CH2OH		C(CS)O
TCMBANKIN035814	(7E)-9-hydroxymegastigma-4, 7-dien-3-on-9-O-beta-D-glucopyranoside_qt			208.33
TCMBANKIN055948	Eupachlorin acetate	enoxaparin;nadroparin	C22H27ClO8	420.453	[C@]12([H])[C@](O[H])(C(C([H])([H])[H])=C([H])[C@@]1([H])OC(=O)C([H])([H])[H])[C@]3([H])[C@]([H])(C(=C([H])[H])C(=O)O3)[C@]([H])(OC(=O)\C(\C([H])([H])[H])=C([H])/C([H])([H])[H])C([H])([H])[C@]2(O[H])C ([H])([H])Cl
TCMBANKIN057911	se	selenium	H2Se	78.97 g/mol	[Se]
TCMBANKIN057965	arginine	L(+ )-arginine;EINECS 230-571-3; (2S)-2-amino-5-guanidino-pentanoic acid; EINECS 200-811-1; (S)-2-Amino-5-guanidinovaleric acid; DL-Arginine; (L)-Arginine; Arginine hydrochloride(USAN); 1-Amino-4-guanidovaleric acid; L-Ornithine, N5-(aminoiminomethyl)-; W381918_ALDRICH; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; Arginine [USAN:INN]; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; L-Arginine, labeled with tritium; AI3-24165; AIDS-121865; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; NSC203450 (HYDROCHLORIDE); A5006_SIAL; (+-)-Arginine; L-Norvaline, 5-((aminoiminomethyl)amino)-; AIDS121865; Lopac0_000077; Tocris-0663; Arginine (VAN); 4455-52-1; CCRIS 3609; BRN 1725413; NCGC00015064-01; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; (2S)-2-amino-5-guanidinopentanoic acid; D02982; Argininum [INN-Latin]; C00062; 7200-25-1; A8094_SIGMA; 11009_FLUKA; Poly(L-arginine); (2S)-2-amino-5-guanidino-valeric acid; Lopac-A-5006; NSC 206269; HSDB 1429; CHEBI:16467; L-Arginine, homopolymer; L-Arginine (9CI); Arginina [INN-Spanish]; 4-04-00-02648 (Beilstein Handbook Reference); (S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; Arginine, L- (8CI); L-Arginine (JP15); EU-0100077; L-alpha-Amino-delta-guanidinovaleric acid; NSC7914 (HYDROCHLORIDE); Arginine (USP); 1119-34-2 (HYDROCHLORIDE); Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; L-Arg; L-Norvaline, 5-[(aminoiminomethyl)amino]-; 142-49-4; A4474_SIAL; InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s; L-Arginin; Arginine, DL-; NCGC00024715-01;AC1ODX8E; [(4S)-5-amino-4-azaniumyl-5-oxopentyl]-(diaminomethylidene)azanium; [AMINO({[(4S)-4-AMMONIO-4-CARBAMOYLBUTYL]AMINO})METHYLIDENE]AZANIUM	C6H14N4O2	174.2 g/mol	C(CC(C(=O)O)N)CN=C(N)N
TCMBANKIN058964	heparin	enoxaparin;nadroparin	C26H42N2O37S5	1134.9 g/mol	CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
TCMBANKIN059684	Vitamin E β-		C29H50O2	430.79	CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O
TCMBANKIN059746	α-tocopherol		C29H50O2	430.7 g/mol	CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000023		Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000166		-	-	Neoplastic Process	disease
TCMBANKDI001279		Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases	Abnormality of the nervous system; Abnormality of blood and blood-forming tissues; Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI002557		Eye Diseases; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases; Stomatognathic Diseases	-	Disease or Syndrome	disease
TCMBANKDI005528		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases	-	Congenital Abnormality	disease
TCMBANKDI007135		-	-	Disease or Syndrome	disease
TCMBANKDI012004		-	-	Disease or Syndrome	disease
TCMBANKDI013924		Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI015186		-	Abnormality of the nervous system	Anatomical Abnormality	phenotype
TCMBANKDI015485		Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI017965		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Finding	phenotype
TCMBANKDI023464		Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI025420		Digestive System Diseases; Neoplasms	Abnormality of the digestive system; Neoplasm	Neoplastic Process	disease
TCMBANKDI026165		Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI026571		Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI028664		-	-	Finding	phenotype
TCMBANKDI029861		Neoplasms; Hemic and Lymphatic Diseases	-	Neoplastic Process	disease
TCMBANKDI031381		Neoplasms; Hemic and Lymphatic Diseases	-	Neoplastic Process	disease